Search
Search Constraints
You searched for: Author/Creator Polyzos, Dimitris- Polyzos, Dimitris [remove] 6
- 616.132005 5
- Hypertension -- Periodicals 5
- 615.105 1
- ADRIFT Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban in Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure -- AF Atrial Fibrillation -- ARISTOTLE Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation -- ATLAS-ACS TIMI 51 Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-TIMI 51 -- CI Confidence Interval -- COMPASS Cardiovascular Outcomes for People Using Anticoagulation Strategies -- CV Cardiovascular -- DOACs Direct Oral Anticoagulants -- ENGAGE AF-TIMI 48 Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation–Thrombolysis in Myocardial Infarction 48 -- GALILEO Global Study Comparing a Rivaroxaban-based Antithrombotic Strategy to an Antiplatelet-based Strategy after Transcatheter Aortic Valve Replacement to Optimize Clinical Outcomes -- PRISMA Preferred Reporting Items for Systematic Reviews and Meta-analyses -- RE-LY Randomized Evaluation of Long-Term Anticoagulation Therapy -- RCTs Randomized Controlled Trials -- RoB2 Revised Cochrane Risk of Bias -- ROCKET AF Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation 1
- Médicaments -- Recherche -- Périodiques 1
- Pharmacologie -- Périodiques 1
- Pharmacology -- Periodicals 1
- Research -- Periodicals 1
- Warfarin -- Non-vitamin K Antagonist Oral Anticoagulant -- Direct oral anticoagulants 1